Glen Harbor Capital Management’s Progenics Pharmaceuticals Inc PGNX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q4 | – | Sell |
-19,908
| Closed | -$125K | – | 1358 |
|
|
2018
Q3 | $125K | Buy |
19,908
+1,428
| +8% | +$8.97K | ﹤0.01% | 1163 |
|
|
2018
Q2 | $148K | Hold |
18,480
| – | – | ﹤0.01% | 1065 |
|
|
2018
Q1 | $138K | Buy |
18,480
+4,340
| +31% | +$32.4K | ﹤0.01% | 1085 |
|
|
2017
Q4 | $84K | Buy |
14,140
+3,584
| +34% | +$21.3K | ﹤0.01% | 1176 |
|
|
2017
Q3 | $78K | Buy |
10,556
+2,548
| +32% | +$18.8K | ﹤0.01% | 1160 |
|
|
2017
Q2 | $54K | Buy |
8,008
+4,284
| +115% | +$28.9K | ﹤0.01% | 1188 |
|
|
2017
Q1 | $35K | Buy |
+3,724
| New | +$35K | ﹤0.01% | 1184 |
|